NASDAQ · Analyst Forecast

Health In Tech, Inc. (HIT) Analyst Forecast

$0.56 NASDAQ: HIT Market Cap $30.14M

Revenue and earnings estimates published by analysts covering Health In Tech, Inc. (HIT), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Health In Tech, Inc., analysts forecast revenue rising from $32.35T in 2025 to $54.13T in 2027; the average estimate for 2027 earnings per share is $-0.00; with published estimates ranging from $-0.01 to $0.00; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

Measure	Value
Current priceWhat the share trades at now.	$0.56
Consensus targetThe average of the price targets analysts have published.	$3.00
Median targetThe middle target, less affected by a single outlier.	$3.00
Highest targetThe most optimistic published target.	$3.00
Lowest targetThe most pessimistic published target.	$3.00
Difference from priceHow far the consensus target sits from today’s price.	+435.7%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2025	$24.26T	$32.35T	$41.38T	1
2026	$26.13T	$34.85T	$44.58T	2
2027	$32.84T	$54.13T	$75.42T	2

Earnings per share forecast

Year	Low	Average	High	Analysts
2025	$0.01	$0.01	$0.02	1
2026	$-0.24	$-0.17	$-0.09	2
2027	$-0.01	$-0.00	$0.00	2

Health In Tech, Inc. (HIT) forecast — frequently asked questions

What is the analyst price target for Health In Tech, Inc.?

Analysts covering Health In Tech, Inc. (HIT) have a consensus price target of $3.00, 435.7% above the current price of $0.56. Published targets range from $3.00 to $3.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Health In Tech, Inc.'s earnings?

The average analyst estimate for Health In Tech, Inc. (HIT) earnings per share in 2027 is -0.00, with individual estimates between -0.01 and 0.00.

How much revenue is Health In Tech, Inc. expected to make?

Analysts forecast Health In Tech, Inc. (HIT) revenue of $54.13T in 2027, based on 2 published estimates.

How many analysts cover HIT?

2 analysts contribute estimates for Health In Tech, Inc. (HIT). Thin coverage makes an average less reliable.

Related stock screens

High ROE Technology Stocks Low P/E Technology Stocks High Net Margin Technology Stocks Dividend Technology Stocks Low Debt Technology Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.